Finance

Lists
CERS:NASDAQ
Cerus Corp
2,26 USD
-1,74%
(-0,040) 1D
2,26 USD
0,00% (0,00)
After hours
Closed: 12-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CERS...
Open
2,29 USD
High
2,30 USD
Low
2,22 USD
Mkt. cap
455,45 млн
Avg. vol.
1,65 млн
Volume
122,00
52-wk high
3,47 USD
52-wk low
1,38 USD
EPS
-0,03 USD
Beta
1,83
Shares outstanding
201,52 млн
No. of employees
268
Open
2,29 USD
High
2,30 USD
Low
2,22 USD
Mkt. cap
455,45 млн
Avg. vol.
1,65 млн
Volume
122,00
52-wk high
3,47 USD
52-wk low
1,38 USD
EPS
-0,03 USD
Beta
1,83
Shares outstanding
201,52 млн
No. of employees
268
News stories
From web sources and news partners
Profile
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
About Cerus Corp
CEO-
Employees268
Foundedсен. 1991
HeadquartersКонкорд, Калифорния, Америка Кошмо Штаттары
SectorMedical device
Websitecerus.com
Analyst ratings
Based on 2 analysts giving stock ratings to CERS in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for CERS in the last 3 months.
Highest
Current 2,26 USD
5,00 USD (+121,24%)
Average
4,50 USD (+99,12%)
Lowest
4,00 USD (+76,99%)
Analyst
Recommendation
Action
Price target
Projected
Date
Josh Jennings
TD Cowen
Buy
Reiterated
5,00 USD
+121,2%
08/28/2026
Mark Massaro
BTIG
Buy
Reiterated
4,00 USD
+77%
08/14/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
05/01/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
52,70 млн
57,75 млн
53,66 млн
57,44 млн
Cost of goods sold
24,56 млн
28,00 млн
25,77 млн
27,91 млн
Cost of revenue
24,56 млн
28,00 млн
25,77 млн
27,91 млн
Research and development expenses
15,82 млн
16,39 млн
14,53 млн
14,39 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,62 млн
20,83 млн
19,95 млн
22,86 млн
Operating expense
26,90 млн
30,39 млн
28,25 млн
31,39 млн
Total operating expenses
51,46 млн
58,39 млн
54,02 млн
59,30 млн
Operating income
1,24 млн
-641,00 миң
-354,00 миң
-1,86 млн
Other non operating income
976,00 миң
578,00 миң
520,00 миң
734,00 миң
EBT including unusual items
65,00 миң
-2,06 млн
-1,56 млн
-2,89 млн
EBT excluding unusual items
65,00 миң
-2,08 млн
-1,56 млн
-2,89 млн
Income tax expense
85,00 миң
119,00 миң
91,00 миң
95,00 миң
Effective tax rate
130,77%
-5,76%
-5,84%
-3,29%
Other operating expenses
-7,54 млн
-6,83 млн
-6,23 млн
-5,86 млн
Net income
-19,00 миң
-2,18 млн
-1,64 млн
-2,94 млн
Net profit margin
-0,04%
-3,78%
-3,06%
-5,12%
Earnings per share
-
-0,01
-0,01
-0,01
Interest and investment income
-
-
-
-
Interest expense
-2,12 млн
-1,96 млн
-1,87 млн
-1,71 млн
Net interest expenses
-2,12 млн
-1,96 млн
-1,87 млн
-1,71 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,62 млн
-248,00 миң
93,00 миң
-1,40 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору